<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<doc>
  <docno>
    <textblock>FR940207-2-00089</textblock>
  </docno>
  <parent>
    <textblock>FR940207-2-00039</textblock>
  </parent>
  <text>
    <textblock>In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following committee meeting:</textblock>
    <textblock>Name:</textblock>
    <textblock>Advisory Committee on Immunization Practices.</textblock>
    <textblock>Times and Dates:</textblock>
    <textblock>8:30 a.m-5 p.m., February 23, 1994. 8:30 a.m.-4:45 p.m., February 24, 1994.</textblock>
    <textblock>Place:</textblock>
    <textblock>CDC, Auditorium A, Building 2, 1600 Clifton Road NE, Atlanta, Georgia 30333.</textblock>
    <textblock>Status:</textblock>
    <textblock>Open to the public, limited only by the space available.</textblock>
    <textblock>Purpose:</textblock>
    <textblock>The committee is charged with advising the Director, CDC, on the appropriate uses of immunizing agents.</textblock>
    <textblock>Matters to be discussed:</textblock>
    <textblock>The committee will discuss ACIP's rule in the ``Vaccines for Children Program''; the ``Vaccines for Children Program'' update; responses to the proposed Federal Register notice on the vaccine schedule recommended for the ``Vaccines for Children Program''; the status of the simplification of the vaccine schedule; an update on large-linked database studies of adverse events; the revision of the varicella statement and the status of the application for licensure of the varicella vaccine; the inactive poliovirus-oral poliovirus schedule; vaccine-associated paralytic poliomyelitis in Romania; the need for an adult booster dose of acellular pertussis vaccine; an update on the typhoid recommendation; the status of BCG vaccine guidelines; the Institute of Medicine report on adverse reactions and contraindications to vaccines; adolescent vaccination against hepatitis B; hepatitis A vaccine; the Department of Defense hepatitis A vaccine trials; hepatitis C virus infection in the occupational setting; influenza vaccine recommendation for 1994/1995; antiviral agents; the status of the development of new vaccine information statements; an update on the National Vaccine Program; and an update on the Injury Compensation Program. Other matters of relevance among the committee's objectives may be discussed.</textblock>
    <textblock>Agenda items are subject to change as priorities dictate.</textblock>
    <textblock>CONTACT PERSON FOR MORE INFORMATION:</textblock>
    <textblock>Gloria A. Kovach, Committee Management Specialist, CDC (1-B72), 1600 Clifton Road NE, Mailstop A20, Atlanta, Georgia 30333, telephone 404/639-3851.</textblock>
    <textblock>Dated: February 1, 1994.</textblock>
  </text>
  <usbureau>
    <textblock>Centers for Disease Control and Prevention</textblock>
  </usbureau>
  <doctitle>
    <textblock>Advisory Committee on Immunization Practices: Meeting</textblock>
  </doctitle>
  <signer>
    <textblock>Elvin Hilyer,</textblock>
  </signer>
  <signjob>
    <textblock>Associate Director for Policy Coordination, Centers for Disease Control and Prevention (CDC).</textblock>
  </signjob>
  <frfiling>
    <textblock>[FR Doc. 94-2655 Filed 2-4-94; 8:45 am]</textblock>
  </frfiling>
  <billing>
    <textblock>BILLING CODE 4160-18-M</textblock>
  </billing>
</doc>
